期刊文献+

胃癌组织B7-H3表达及其临床意义的探讨

Significance of expression of B7-H3 in human gastric carcinoma tissues
原文传递
导出
摘要 目的:研究B7-H3在胃癌组织中的表达及其与各临床病理变量之间的相关性。方法:采用免疫组织化学法检测113例胃癌手术标本中B7-H3蛋白的表达,分析其与肿瘤浸润性T淋巴细胞及各临床病理参数间的相关性。结果:B7-H3在胃癌组织中高表达(46.9%,53/113);B7-H3的表达与肿瘤浸润性T淋巴细胞呈负相关,P<0.05。淋巴结阳性组中B7-H3+群的百分比(54.8%,40/73)高于无淋巴结转移组(32.5%,13/40),P<0.05。Ⅰ、Ⅱ期患者标本中B7-H3的阳性表达率要明显低于Ⅲ+Ⅳ期组,P<0.05。结论:B7-H3在胃癌组织中高表达,与肿瘤分期、淋巴结转移正相关,与肿瘤浸润T淋巴细胞呈负相关。B7-H3可能通过抑制间质中T细胞的浸润介导胃癌肿瘤免疫逃逸。 OBJECTIVE:To study the expression of B7-H3 and its relation with cancer clinicopathological variables in gastric carcinoma tissues. METHODS:The expression of B7-H3 in 113 surgically resected specimens of gastric carcinoma was evaluated immunohistochemically. RESULTS: In these tumor specimens, 46.9%(53/113) of specimens was positive for B7-H3, which was observed in the cell membrane and/or cytoplasm. The number of T infiltrating lymphoid cells (TILs) in the tumor tissues was much lower in the B7 H3 positive cases than the negative cases(P〈0.05). And it was found that B7-H3 expression was significantly more common in cases with lymph node metastasis [54.8%(40/73) vs 32.5% (13/40)) and stage Ⅲ+Ⅳ(P〈0.05). CONCLUSION:B7-H3 is expressed in the tissues of gastric carcinoma, and B7 H3 expression is negatively correlated with the number of TILs,which may represent one of the immune escape mechanisms for gastric carcinoma.
出处 《中华肿瘤防治杂志》 CAS 2011年第12期946-948,共3页 Chinese Journal of Cancer Prevention and Treatment
基金 山东省优秀中青年科学家奖励基金(2006BS03015)
关键词 B7-H3 胃肿瘤 免疫组织化学 肿瘤浸润性T淋巴细胞 B7-H3 stomach neoplasms immunohistochemistry infiltrating lymphoid cells
  • 相关文献

参考文献10

  • 1Ling V, Wu P W, Spaulding V, et al, Duplication of primate and rodent B7 H3 immunoglobulin V- and C-like domains: diver gent history of functional redundancy and exon loss[J]. Genom ics, 2003, 82(3): 365-377.
  • 2Hansen J D, Du Pasquier L, Lefranc M P, et al, The B7 family of immunoregulatory receptors: a comparative and evolutionary perspective[J]. Mol Immunol,2009,46(3) :457-472.
  • 3Tran C N, Thacker S G, Louie D M,et al. Interactions of T cells with fibroblast like synoviocytes role of the B7 family cos timulatory ligand B7-H3[J]. J Immunol, 2008,180(5) : 2989- 2998.
  • 4Sun Y, Wang Y, Zhao J, et al. B7-H3 and B7 H4 expression in non-small-cell lung cancer[J]. Lung Cancer, 2006,53 (2) : 143-152.
  • 5Zang X, Thompson R H, Al Ahmadie H A, et al. B7 H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outeome[J]. Proc Natl Acad Sci U S A,2007,104(49) :19458-19463.
  • 6Crispen P L, Sheinin Y, Roth T J, et al. Tumor cell and tumor vasculature expression of B7 H3 predict survival in clear cell re nalcell carcinoma[J]. Clin Cancer Res, 2008, 14(16):5150-5157.
  • 7Chapoval A I, Ni J, Lau J S, et al. B7 H3: a costimulatory molecule for T cell activation and IFN 3 production[J]. Nat. Immunol, 2001,2(3) : 269-274.
  • 8Luo L Q, Chapoval A I, Flies D B, et al. BT-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8 (2) cytolytic T cells[J]. J Immunol, 2004,173(9) :5445-5450.
  • 9Leitner J, Klauser C, Pickl W F,et al. B7-H3 is a potent inhibi tor of human T cell activation: No evidence for B7 H3 and TREML2 interaetion[J]. Eur J Immunol, 2009,39(7):1754-1764.
  • 10Hashiguchi M, Kobori H, Ritprajak P, et al. Triggering recep- tor expressed on myeloid cell like transcript 2 (TLT-2) is a counterreceptor for B7-H3 and enhances T cell responses[J]. ProcNatl Acad Sci U S A, 2008,105(30):10495-10500.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部